Home / Resource Library / Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLLFactors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL Study examined CAR-T therapy for treatment of relapsed CLL.